CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

We compared morphologic computed tomography (CT)-based to metabolic fluoro-deoxy-glucose (FDG) positron emission tomography (PET)/CT-based response evaluation in patients with metastatic colorectal cancer and correlated the findings with survival and KRAS status. From 2006 to 2009, patients were inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Skougaard, Kristin, Johannesen, Helle Hjorth, Nielsen, Dorte, Schou, Jakob Vasehus, Jensen, Benny Vittrup, Høgdall, Estrid V S, Hendel, Helle Westergren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302679/
https://www.ncbi.nlm.nih.gov/pubmed/24941936
http://dx.doi.org/10.1002/cam4.271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302679/
https://www.ncbi.nlm.nih.gov/pubmed/24941936
http://dx.doi.org/10.1002/cam4.271

Ejemplares similares